Watch stocks you care about
The single, easiest way to keep track of all the stocks that matter...
Your own personalized stock watchlist!
It's a 100% FREE Motley Fool service...
Health care is about to change for a patient population called "the poorest and the sickest" by the Kaiser Family Foundation.
Spend enough time reading about Medicare or Medicaid and you will see the term "dual-eligible," which refers to people who qualify for both programs due to low income combined with chronic illness or disability. Dual-eligible patients represent a small percentage of both programs but amount to a much higher chunk of overall costs.
The Affordable Care Act has provisions aimed at streamlining this system and some trial programs to begin next month. But profits still await private insurers -- if they're willing and able to take the risk.
Dual-eligible patients typically have Medicare as the primary payer for general health care costs, which include doctor and hospital visits and prescription drugs. Medicaid steps in to help cover Medicare costs and plug any gaps in that primary coverage. The costs of treating dual-eligible patients are disproportionately high. While only 15% of Medicaid patients qualify for Medicare, those patients represent 36% of total Medicaid spending, according to the KFF.
The higher costs offer an opportunity for insurer profits, assuming the company doesn't mind taking on a patient population known for poorer health.
Private insurers need a presence in the Medicare and Medicaid markets to benefit fully from dual-eligible patients. The first checkmark is easier to mark off; most of the leading insurers have a Medicare Advantage or Part D program kicking around. But fewer have a strong Medicaid program already in place.
An exception to the rule is UnitedHealth (NYSE: UNH ) . The company's Medicare & Retirement segment included 2.6 million Medicare Advantage members, which helped contribute to $39 billion in revenues in its Medicare & Retirement segment last year. Community & State had 3.8 million Medicaid beneficiaries and revenues of $16.4 billion. According to UnitedHealth, these patient numbers include about 250,000 with dual eligibility.
UnitedHealth's current strength came from its 2012 acquisition of XLHealth -- a leader in Medicare Advantage that primarily focused on dual-eligible patients. Other insurers have also tried to secure stronger footing through acquisitions or partnerships.
Humana (NYSE: HUM ) had $25 billion in premium revenues for individual Medicare Advantage beneficiaries from about 2.2 million members. The company's Medicaid presence was lacking before collaborating with CareSource, a provider with around 900,000 enrollees in Ohio and Michigan.
WellPoint (NYSE: ANTM ) spent $800 million on CareMore Health Group, which owned a number of health care clinics tailored to older patients and maintained Medicare Advantage plans. But it was WellPoint's multi-billion dollar acquisition of Amerigroup last year that boosted the company's Medicaid enrollment to 4.5 million patients across 20 states. WellPoint affiliates also announced an expansion of its Medicare offerings last year to increase coverage in eight states.
UnitedHealth and WellPoint are better mobilized going toward the ACA-affiliated changes next year. But all three companies will play a role in test programs coming soon.
In 2011, the Center for Medicare and Medicaid Innovation awarded million-dollar contracts to 15 states that were tasked with designing a better system for dual-eligible patients. The states had a year to submit design proposals and then narrow them down to four participants that will begin their approved programs next month. Each program will have a three-year initial run.
The plans vary in offered benefits, target population, delivery models, and financing. But the main purpose remains streamlining care to both improve the costs of dual-eligible patients while also improving quality.
A select group of private insurers will serve these programs. UnitedHealth and WellPoint's CareSource are two of the enrollees in Ohio's trial program. Humana joined them for the design of Washington's program.
We'll have to wait and see what the involvements mean for company finances in the future. But for now, it's good to be on the front line of the health care changes.
Foolish final thoughts
Insurers have taken considerable strides to pursue dual-eligible patients. UnitedHealth has had the strongest standing, but WellPoint could start nipping at its heels, thanks to the Amerigroup acquisition.
Ultimately, the ACA has so many changes coming in the next year that it will take some time for the dust to settle. But the companies establishing places at the front now will likely stay there.
The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in the brand-new free report: "The Motley Fool's Top Stock for 2013." Just click here to access the report and find out the name of this under-the-radar company.